Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.0B | 7.2B | 6.0B |
Cost of revenue | 3.9B | 3.6B | 5.9B | 5.4B |
Gross profit | 485.6M | 418.0M | 1.3B | 633.4M |
Operating expense | ||||
Research & development | 138.6M | 128.1M | 124.6M | 115.3M |
Selling general and admin | 280.6M | 273.6M | 288.8M | 245.7M |
Other operating expenses | — | — | — | — |
Operating income | 66.4M | 16.3M | 882.6M | 272.5M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 53.6M | 8.2M | 996.7M | 214.3M |
Tax provision | 14.0M | 2.3M | 300.4M | 66.4M |
Net income | 39.6M | 5.8M | 696.3M | 147.9M |
Basic EPS | 0.0 | 0 | — | 0.0 |
Diluted EPS | 0.0 | 0 | — | 0.0 |
Basic average shares | 3.7B | 3.5B | — | 3.4B |
Diluted average shares | 3.7B | 3.5B | — | 3.4B |
EBITDA | 66.4M | 9.3M | 999.1M | 277.1M |
Net income from continuing op. | 39.6M | 5.8M | 696.3M | 147.9M |
Minority interests | -2.3M | 0 | 0 | 0 |
Preferred stock dividends | 0 | 0 | 0 | 0 |